Le Lézard
Classified in: Health
Subject: MRR

Homecare Oxygen Concentrators Market growth to accelerate at 15% CAGR -- North America to occupy 36% market share

The 120 pages report segments the homecare oxygen concentrators market by product (portable and stationary) and geography (North America, Europe, Asia, and ROW)

NEW YORK, Aug. 18, 2022 /PRNewswire/ -- The global homecare oxygen concentrators market size is expected to grow by USD 1.21 billion between 2020 and 2025. The market witnessed a YOY growth of 14.83% in 2021 and the growth momentum is expected to accelerate at a CAGR of about 15% during the forecast period. The report provides detailed insights into the market growth across segments and geographies. Understand the scope of the full report. Download Sample PDF Report Now

By product, the portable homecare oxygen concentrators segment generated significant growth opportunities for market players in 2021. Factors such as ease of travel, compactness, and long-lasting battery life are increasing their adoption among end-users. Also, the growing demand for flexible, compact, and user-friendly products are further accelerating the growth of the market in the segment.

By region, the market observed significant growth in North America in 2021. The availability of advanced healthcare facilities, rising healthcare spending, and the presence of government bodies such as Medicaid that help with medical costs for individuals with limited income and resources are driving the growth of the regional market. The high prevalence of respiratory diseases in the US and Canada is also contributing to the growth of the homecare oxygen concentrators market in North America.

Homecare Oxygen Concentrators Market: Major Growth Drivers

The following factors are expected to drive the growth of the market during the forecast period:

The prevalence of various respiratory diseases is increasing significantly across the globe. This can be attributed to a rise in risk factors such as allergy, pollution, and smoking. In addition, many individuals face shortness of breath while performing non-strenuous activities such as walking up a flight of stairs, playing golf, or walking uphill. In addition, the rise in the aging population, especially in countries such as Japan, the UK, the US, and Germany has further increased the prevalence of various respiratory diseases such as tuberculosis, COPD, and bronchial asthma. All these factors have necessitated the need for advanced medical technologies such as homecare oxygen concentrators, thereby driving the growth of the market.

The full report on the homecare oxygen concentrators market helps businesses create strategies to make the most of future growth opportunities. Download Sample Report Now

Homecare Oxygen Concentrators Market: Key Vendor Offerings
Reasons to Buy Homecare Oxygen Concentrators Market Report:

This report can be personalized to suit your business requirements. Enquire Now

Related Reports:


Homecare Oxygen Concentrators Market Scope

Report Coverage


Page number


Base year


Forecast period


Growth momentum & CAGR

Accelerate at a CAGR of 15%

Market growth 2021-2025

USD 1.21 billion

Market structure


YoY growth (%)


Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 36%

Key consumer countries

US, China, UK, India, and Germany

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Besco Medical Ltd., Drive DeVilbiss Healthcare Ltd., GCE Holding AB, Inogen Inc., Koninklijke Philips NV, Nidek Medical Products Inc., Precision Medical Inc., ResMed Inc., and Teijin Ltd.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Contents:

Executive Summary

Market Landscape

Market Sizing

Five Forces Analysis

Market Segmentation by Product

Customer landscape

Geographic Landscape

Vendor Landscape

Vendor Analysis


About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

These press releases may also interest you

at 00:01
The Centers for Disease Control and Prevention today releases provisional data on suicide deaths for the year 2021. According to the new data, suicide deaths in the United States increased from 45,979 to 47,646 (4%) between the years 2020 and 2021....

29 sep 2022
The FDA approves AMX0035, the first new treatment for ALS in years. The new treatment was funded by donations from the Ice Bucket Challenge, the 2014 social media phenomenon that swept the globe, with 17 million participants raising $115 million for...

29 sep 2022
Coco Life Foundation (Cocolife.black), launched in 2019, is a 501(c)(3) organization based in Philadelphia, PA. Its goal is to eliminate racial disparities in care and improve maternal health outcomes for Black mothers nationwide. Essential services...

29 sep 2022
The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of sodium phenylbutyrate/taurursodiol (Relyvrio) for the treatment of amyotrophic lateral sclerosis (ALS), on September 29. Relyvrio will be made...

29 sep 2022
Vitality Products Inc. (the "Company" or "Vitality") is pleased to report its financial results for the second quarter ended July 31, 2022....

29 sep 2022
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the European Medicines Agency (EMA) has accepted for regulatory review the company's marketing authorization application (MAA) for fezolinetant, an...

News published on 18 august 2022 at 22:35 and distributed by: